Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Paragon Care Limited ( (AU:PGC) ) has issued an announcement.
Paragon Care Limited announced a change in the director’s interest, with Peter Egglestone acquiring an additional 200,000 ordinary shares through an on-market trade, increasing his indirect holding to 300,000 shares. This move could indicate confidence in the company’s future prospects and may have implications for stakeholders regarding the company’s market positioning and potential growth.
The most recent analyst rating on (AU:PGC) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on Paragon Care Limited stock, see the AU:PGC Stock Forecast page.
More about Paragon Care Limited
Paragon Care Limited operates in the healthcare industry, providing a range of medical equipment and services. The company focuses on delivering high-quality healthcare solutions to meet the needs of medical professionals and institutions.
Average Trading Volume: 426,034
Technical Sentiment Signal: Sell
Current Market Cap: A$471.8M
For a thorough assessment of PGC stock, go to TipRanks’ Stock Analysis page.